Rockwell Medical Announces Iron Delivery Drug SFP Meets Primary Endpoint in PRIME Clinical Study Demonstrating Statistically Significant 37% Reduction in ESA Dose WIXOM, Mich., Feb. 4, 2013 -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback